|
1
|
Liu CJ, Lin SC, Chen YJ, Chang KM and
Chang KW: Array-comparative genomic hybridization to detect
genomewide changes in microdissected primary and metastatic oral
squamous cell carcinomas. Mol Carcinog. 45:721–731. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shieh TM, Lin SC, Liu CJ, Chang SS, Ku TH
and Chang KW: Association of expression aberrances and genetic
polymorphisms of lysyl oxidase with areca-associated oral
tumorigenesis. Clin Cancer Res. 13:4378–4385. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schmitz S, Ang KK, Vermorken J, Haddad R,
Suarez C, Wolf GT, Hamoir M and Machiels JP: Targeted therapies for
squamous cell carcinoma of the head and neck: Current knowledge and
future directions. Cancer Treat Rev. 40:390–404. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Allegra CJ, Jessup JM, Somerfield MR,
Hamilton SR, Hammond EH, Hayes DF, McAllister PK, Morton RF and
Schilsky RL: American society of clinical oncology provisional
clinical opinion: Testing for KRAS gene mutations in patients with
metastatic colorectal carcinoma to predict response to
anti-epidermal growth factor receptor monoclonal antibody therapy.
J Clin Oncol. 27:2091–2096. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cancer Genome Atlas Research Network, .
Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA,
Ellrott K, Shmulevich I, Sander C and Stuart JM: The cancer genome
atlas pan-cancer analysis project. Nat Genet. 45:1113–1120. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Verhaak RG, Hoadley KA, Purdom E, Wang V,
Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al:
Integrated genomic analysis identifies clinically relevant subtypes
of glioblastoma characterized by abnormalities in PDGFRA, IDH1,
EGFR, and NF1. Cancer Cell. 17:98–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cancer Genome Atlas Research Network:
Integrated genomic analyses of ovarian carcinoma. Nature.
474:609–615. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cancer Genome Atlas Research Network:
Comprehensive genomic characterization of squamous cell lung
cancers. Nature. 489:519–525. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cancer Genome Atlas Network: Comprehensive
molecular characterization of human colon and rectal cancer.
Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Forbes SA, Bindal N, Bamford S, Cole C,
Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, et al:
COSMIC: Mining complete cancer genomes in the catalogue of somatic
mutations in cancer. Nucleic Acids Res. 29:D945–D950. 2011.
View Article : Google Scholar
|
|
12
|
Collins FS and Barker AD: Mapping the
cancer genome. Scientific American. 296:50–57. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stratton MR, Campbell PJ and Futreal PA:
The cancer genome. Nature. 458:719–724. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Emanuele E, Lista S, Ghidoni R, Binetti G,
Cereda C, Benussi L, Maletta R, Bruni AC and Politi P: Chromosome
9p21.3 genotype is associated with vascular dementia and
Alzheimer's disease. Neurobiol Aging. 32:1231–1235. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: an open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Barnes L, Eveson JW, Reichart P and
Sidransky D: Pathology and genetics of head and neck tumours. IARC.
2005.
|
|
18
|
Wu N, Liu C, Bai C, Han YP, Cho WC and Li
Q: Over-expression of deubiquitinating enzyme USP14 in lung
adenocarcinoma promotes proliferation through the accumulation of
beta-catenin. Int J Mol Sci. 14:10749–10760. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu N, Zhang C, Bai C, Han YP and Li Q:
miR-4782-3p Inhibited non-small cell lung cancer growth via USP14.
Cell Physiol Biochem. 33:457–467. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song B, Zhang C, Li G, Jin G and Liu C:
MiR-940 inhibited pancreatic ductal adenocarcinoma growth by
targeting MyD88. Cell Physiol Biochem. 35:1167–1177. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong
Q, Qin L, Wu X, Zheng Y, Yang Y, et al: Identification of miRNomes
in human liver and hepatocellular carcinoma reveals miR-199a/b-3p
as therapeutic target for hepatocellular carcinoma. Cancer Cell.
19:232–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lu J, Wen M, Huang Y, He X, Wang Y, Wu Q,
Li Z, Castellanos-Martin A, Abad M, Cruz-Hernandez JJ, et al:
C2ORF40 suppresses breast cancer cell proliferation and invasion
through modulating expression of M phase cell cycle genes.
Epigenetics. 8:571–583. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cancer Genome Atlas Network: Comprehensive
genomic characterization of head and neck squamous cell carcinomas.
Nature. 517:576–582. 2015. View Article : Google Scholar : PubMed/NCBI
|
